Changeflow GovPing Healthcare Citizen Petition from Charlene Peters
Routine Notice Added Final

Citizen Petition from Charlene Peters

Email

Summary

The Food and Drug Administration (FDA) has received a citizen petition from Charlene Peters. The petition is currently available for review, with a redacted version provided for public access.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The FDA has received a citizen petition filed by Charlene Peters. While the full document contains personally identifiable information and is restricted, a redacted version is available for public access via Regulations.gov. The petition was submitted to the Center for Drug Evaluation and Research (CDER).

This filing represents a new submission to the FDA's regulatory process. Compliance officers should note that while this is a citizen petition and not a rule or enforcement action, such petitions can influence future FDA policy or regulatory actions concerning drug products. No immediate compliance actions are required based on this filing, but awareness of the petition's existence and subject matter may be relevant for entities operating within the pharmaceutical sector.

Archived snapshot

Mar 28, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 2

Citizen Petition from Charlene Peters

Restricted: Personally Identifiable Information

More Information
- Author(s) CDER

Citizen Petition from Charlene Peters - Redacted

More Information
- Author(s) CDER
Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
FDA-2026-P-3169-0001
Docket
FDA-2026-P-3169-0001

Who this affects

Applies to
Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Petitioning
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Compliance frameworks
FDA 21 CFR Part 11
Topics
Drug Safety Regulatory Affairs

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!